Vaxil Bio Current Valuation vs. Net Asset
| VXL Stock | CAD 0.01 0.00 0.00% |
For Vaxil Bio profitability analysis, we use financial ratios and fundamental drivers that measure the ability of Vaxil Bio to generate income relative to revenue, assets, operating costs, and current equity. These fundamental indicators attest to how well Vaxil Bio utilizes its assets to generate profit and value for its shareholders. The profitability module also shows relationships between Vaxil Bio's most relevant fundamental drivers. It provides multiple suggestions of what could affect the performance of Vaxil Bio over time as well as its relative position and ranking within its peers.
Vaxil |
Vaxil Bio Net Asset vs. Current Valuation Fundamental Analysis
Comparative valuation techniques use various fundamental indicators to help in determining Vaxil Bio's current stock value. Our valuation model uses many indicators to compare Vaxil Bio value to that of its competitors to determine the firm's financial worth. Vaxil Bio is rated first in current valuation category among its peers. It is rated first in net asset category among its peers making up about 2.17 of Net Asset per Current Valuation. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Vaxil Bio's earnings, one of the primary drivers of an investment's value.Vaxil Current Valuation vs. Competition
Vaxil Bio is rated first in current valuation category among its peers. After adjusting for long-term liabilities, total market size of Health Care industry is at this time estimated at about 20.51 Trillion. Vaxil Bio adds roughly 449,789 in current valuation claiming only tiny portion of equities under Health Care industry.
Vaxil Net Asset vs. Current Valuation
Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Vaxil Bio |
| = | 449.79 K |
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
Net Asset is the current market value of a fund less its liabilities. In a nutshell, if the fund is liquidated or all of the assets is sold out, the net asset will be the amount that the shareholders would demand back from the fund.
Vaxil Bio |
| = | 976 K |
Net Asset is the value used in calculating NAV of a fund. NAV (or Net Asset Value) is computed once a day based on the formula that uses closing prices of all positions in the fund's portfolio.
Vaxil Net Asset Comparison
Vaxil Bio is currently under evaluation in net asset category among its peers.
Vaxil Bio Profitability Projections
The most important aspect of a successful company is its ability to generate a profit. For investors in Vaxil Bio, profitability is also one of the essential criteria for including it into their portfolios because, without profit, Vaxil Bio will eventually generate negative long term returns. The profitability progress is the general direction of Vaxil Bio's change in net profit over the period of time. It can combine multiple indicators of Vaxil Bio, where stable trends show no significant progress. An accelerating trend is seen as positive, while a decreasing one is unfavorable. A rising trend means that profits are rising, and operational efficiency may be rising as well. A decreasing trend is a sign of poor performance and may indicate upcoming losses.
| Last Reported | Projected for Next Year | ||
| Accumulated Other Comprehensive Income | 4.2 M | 2.3 M | |
| Operating Income | (254.00) | (266.70) | |
| Income Before Tax | (254.00) | (266.70) | |
| Net Loss | -254 K | -266.7 K | |
| Total Other Income Expense Net | 4.5 K | 4.7 K | |
| Income Tax Expense | 12.7 K | 13.3 K | |
| Net Loss | -254 K | -266.7 K | |
| Net Loss | -1.1 M | -1.2 M | |
| Net Interest Income | 3.6 K | 3.8 K | |
| Interest Income | 9 K | 8 K | |
| Change To Netincome | 63 K | 59.9 K | |
| Income Quality | 2.21 | 2.32 |
Vaxil Profitability Driver Comparison
Profitability drivers are factors that can directly affect your investment outlook on Vaxil Bio. Investors often realize that things won't turn out the way they predict. There are maybe way too many unforeseen events and contingencies during the holding period of Vaxil Bio position where the market behavior may be hard to predict, tax policy changes, gold or oil price hikes, calamities change, and many others. The question is, are you prepared for these unexpected events? Although some of these situations are obviously beyond your control, you can still follow the important profit indicators to know where you should focus on when things like this occur. Below are some of the Vaxil Bio's important profitability drivers and their relationship over time.
Use Vaxil Bio in pair-trading
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Vaxil Bio position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Vaxil Bio will appreciate offsetting losses from the drop in the long position's value.Vaxil Bio Pair Trading
Vaxil Bio Pair Trading Analysis
The ability to find closely correlated positions to Vaxil Bio could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Vaxil Bio when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Vaxil Bio - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Vaxil Bio to buy it.
The correlation of Vaxil Bio is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Vaxil Bio moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Vaxil Bio moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Vaxil Bio can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Use Investing Themes to Complement your Vaxil Bio position
In addition to having Vaxil Bio in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.Did You Try This Idea?
Run Obamacare Thematic Idea Now
Obamacare
Health care services and providers including hospitals, clinics and nursing homes that hope to benefit from Obamacare program. The Obamacare theme has 37 constituents at this time.
You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Obamacare Theme or any other thematic opportunities.
| View All Next | Launch |
Additional Tools for Vaxil Stock Analysis
When running Vaxil Bio's price analysis, check to measure Vaxil Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Vaxil Bio is operating at the current time. Most of Vaxil Bio's value examination focuses on studying past and present price action to predict the probability of Vaxil Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Vaxil Bio's price. Additionally, you may evaluate how the addition of Vaxil Bio to your portfolios can decrease your overall portfolio volatility.